[1] |
Chinese Society of Hepatology, Chinese Medical Association. Chinese guidelines on the management of liver cirrhosis[J]. J Clin Hepatol, 2019, 35(11): 2408-2425. DOI: 10.3969/j.issn.1001-5256.2019.11.006.
中华医学会肝病学分会. 肝硬化诊治指南[J]. 临床肝胆病杂志, 2019, 35(11): 2408-2425. DOI: 10.3969/j.issn.1001-5256.2019.11.006.
|
[2] |
SASS DA, CHOPRA KB. Portal hypertension and variceal hemorrhage[J]. Med Clin North Am, 2009, 93(4): 837-853, ⅶ-ⅷ. DOI: 10.1016/j.mcna.2009.03.008.
|
[3] |
WAN SZ, NIE Y, ZHANG Y, et al. Assessing the prognostic performance of the Child-Pugh, Model for End-Stage Liver Disease, and Albumin-Bilirubin scores in patients with decompensated cirrhosis: A large asian cohort from gastroenterology department[J]. Dis Markers, 2020, 2020: 5193028. DOI: 10.1155/2020/5193028.
|
[4] |
KAMATH PS, WIESNER RH, MALINCHOC M, et al. A model to predict survival in patients with end-stage liver disease[J]. Hepatology, 2001, 33(2): 464-470. DOI: 10.1053/jhep.2001.22172.
|
[5] |
PUGH RN, MURRAY-LYON IM, DAWSON JL, et al. Transection of the oesophagus for bleeding oesophageal varices[J]. Br J Surg, 1973, 60(8): 646-649. DOI: 10.1002/bjs.1800600817.
|
[6] |
CREMERS I, RIBEIRO S. Management of variceal and nonvariceal upper gastrointestinal bleeding in patients with cirrhosis[J]. Therap Adv Gastroenterol, 2014, 7(5): 206-216. DOI: 10.1177/1756283X14538688.
|
[7] |
D'AMICO G, GARCIA-TSAO G, PAGLIARO L. Natural history and prognostic indicators of survival in cirrhosis: A systematic review of 118 studies[J]. J Hepatol, 2006, 44(1): 217-231. DOI: 10.1016/j.jhep.2005.10.013.
|
[8] |
JOHNSON PJ, BERHANE S, KAGEBAYASHI C, et al. Assessment of liver function in patients with hepatocellular carcinoma: A new evidence-based approach-the ALBI grade[J]. J Clin Oncol, 2015, 33(6): 550-558. DOI: 10.1200/JCO.2014.57.9151.
|
[9] |
BIYIK M, UCAR R, SOLAK Y, et al. Blood neutrophil-to-lymphocyte ratio independently predicts survival in patients with liver cirrhosis[J]. Eur J Gastroenterol Hepatol, 2013, 25(4): 435-441. DOI: 10.1097/MEG.0b013e32835c2af3.
|
[10] |
MALINCHOC M, KAMATH PS, GORDON FD, et al. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts[J]. Hepatology, 2000, 31(4): 864-871. DOI: 10.1053/he.2000.5852.
|
[11] |
XAVIER SA, VILAS-BOAS R, BOAL CARVALHO P, et al. Assessment of prognostic performance of Albumin-Bilirubin, Child-Pugh, and Model for End-stage Liver Disease scores in patients with liver cirrhosis complicated with acute upper gastrointestinal bleeding[J]. Eur J Gastroenterol Hepatol, 2018, 30(6): 652-658. DOI: 10.1097/MEG.0000000000001087.
|
[12] |
PORTE RJ, LISMAN T, TRIPODI A, et al. The International Normalized Ratio (INR) in the MELD score: Problems and solutions[J]. Am J Transplant, 2010, 10(6): 1349-1353. DOI: 10.1111/j.1600-6143.2010.03064.x.
|
[13] |
KNOX JJ. Addressing the interplay of liver disease and hepatocellular carcinoma on patient survival: The ALBI scoring model[J]. J Clin Oncol, 2015, 33(6): 529-531. DOI: 10.1200/JCO.2014.59.0521.
|
[14] |
LEI Q, ZHANG Y, KE C, et al. Value of the albumin-bilirubin score in the evaluation of hepatitis B virus-related acute-on-chronic liver failure, liver cirrhosis, and hepatocellular carcinoma[J]. Exp Ther Med, 2018, 15(3): 3074-3079. DOI: 10.3892/etm.2018.5748.
|
[15] |
CHAN AW, CHAN RC, WONG GL, et al. New simple prognostic score for primary biliary cirrhosis: Albumin-bilirubin score[J]. J Gastroenterol Hepatol, 2015, 30(9): 1391-1396. DOI: 10.1111/jgh.12938.
|
[16] |
ZOU D, QI X, ZHU C, et al. Albumin-bilirubin score for predicting the in-hospital mortality of acute upper gastrointestinal bleeding in liver cirrhosis: A retrospective study[J]. Turk J Gastroenterol, 2016, 27(2): 180-186. DOI: 10.5152/tjg.2016.15502.
|
[17] |
LU JJ, ZHANG L, DING SG, et al. The prognosis of liver cirrhotic patients with acute esophageal variceal bleeding: A Cox regression analysis[J]. Chin J Dig, 2011, 31(4): 217-220. DOI: 10.3760/cma.j.issn.0254-1432.2011.04.001.
陆京京, 张莉, 丁士刚, 等. 肝硬化食管静脉曲张破裂出血患者预后Cox回归分析[J]. 中华消化杂志, 2011, 31(4): 217-220. DOI: 10.3760/cma.j.issn.0254-1432.2011.04.001.
|
[18] |
CUI S, WANG F, LYU HM, et al. Value of Glasgow-Blatchford score in predicting early prognosis of cirrhotic patients with esophagogastric variceal bleeding[J]. J Clin Hepatol, 2017, 33(10): 1939-1943. DOI: 10.3969/j.issn.1001-5256.2017.10.018.
崔舒, 王芳, 吕洪敏, 等. Glasgow-Blatchford评分对肝硬化食管胃底静脉曲张破裂出血患者早期预后的预测价值[J]. 临床肝胆病杂志, 2017, 33(10): 1939-1943. DOI: 10.3969/j.issn.1001-5256.2017.10.018.
|
1. | 芦建慧,李勇利,郭瑞芳,薛荣泉. 胆囊切除术后原发性胆总管结石复发患者的临床特征分析. 临床肝胆病杂志. 2025(01): 118-126 . ![]() | |
2. | 陈大勇,郭宏志,李权. 腹腔镜胆囊切除术联合同期内镜逆行胰胆管造影术治疗高龄胆囊结石合并继发性胆总管结石患者的效果. 河南医学研究. 2024(06): 1060-1063 . ![]() | |
3. | 仝甲钊,曹振振,孙正路,周从顺,魏书堂. 胆总管结石合并十二指肠乳头旁憩室老年患者ERCP取石成功的影响因素. 河南医学研究. 2024(08): 1358-1362 . ![]() | |
4. | 李梦珂,李渊,王建伟. 胆囊结石合并胆总管多发结石治疗效果及其logistic回归分析. 黑龙江医学. 2024(17): 2054-2057 . ![]() | |
5. | 范嗣琪,魏然,魏杰,李富贵. 乳头夹闭成型+胆总管取石术治疗胆总管结石伴急性胆管炎的应用体会. 腹腔镜外科杂志. 2024(10): 741-746 . ![]() | |
6. | 李泳,周鸿鲲. 不同手术方法治疗胆囊切除后胆总管结石患者的临床疗效分析. 浙江创伤外科. 2023(06): 1118-1120 . ![]() | |
7. | 雷文俤,常贵建,卓信斌,林德新. 胆道冲洗装置在腹腔镜胆总管切开取石术中的应用体会. 腹腔镜外科杂志. 2023(08): 604-608 . ![]() | |
8. | 刘小红,刘洋,武起美. 肾结石行微创手术患者术后复发的影响因素及其防护对策分析. 内蒙古医学杂志. 2023(07): 875-877 . ![]() | |
9. | 吴灵燕,王晓荣,陈柳勇,徐陈柯,黄作斌. 超声联合CT检查在胆总管结石诊断中的应用价值及其漏诊的相关因素分析. 浙江创伤外科. 2023(07): 1372-1374 . ![]() | |
10. | 林秀苹,林洁君,郑艳莉. 彩色多普勒超声术前诊断胆囊结石效能及术后评估结石复发的危险因素分析. 浙江创伤外科. 2023(10): 1954-1957 . ![]() | |
11. | 云逸飞,王林恒,江贵,卢心毓,黄朔,何寅家,张丽杰. 单人经口胆道镜系统直视下与传统X线下非困难性胆总管结石取石的对比研究. 中华消化内镜杂志. 2023(09): 707-712 . ![]() | |
12. | 王亮,陈信浩. 腹腔镜胆囊切除术联合胆总管探查术治疗胆总管结石对患者肝功能及炎性应激反应的影响. 药物生物技术. 2023(06): 614-617 . ![]() |